Thursday, October 28, 2021
Home Featured


It is unclear that Congress will pass a bill that lowers high prescription drug prices – thanks to drug companies and their allies. Americans are paying way too much on their prescriptions when compared to other nations. There is an ongoing public outcry about reducing prescription drug prices.
AstraZeneca has won a federal court ruling upholding key patent for its blockbuster diabetes drug Farxiga (dapagliflozin), a sodium-glucose transport protein 2 (SGLT2) inhibitor. The ruling will now stave off threats from cheaper generic versions of the drug.
Many insurers are now covering claims of behavioral therapy of most distressed dogs, especially those who are suffering from separation anxiety. Most people are trying to hand over dogs for adoption since COVID restrictions have been lifted, making the pets vulnerable to separation anxiety.
A new animal study by UBC researchers has found cancer chemotherapy drug Axitinib reverses the symptoms of Alzheimer’s disease by curbing angiogenesis – the formation of new blood vessels in the brain. The drug improved cognition and memory in mice with Alzheimer’s disease.
A new South Korean study has found an ideal blood sugar target to prevent stroke, heart attack, or other vascular issues. The study has suggested that people with diabetes should keep their HbA1c level in the 6.8% to 7% range in order to stay away from a stroke or heart attack.
AARP (formerly called the American Association of Retired Persons) has mentioned stories of a few patients who are affected by high prescription drug prices. Despite being enrolled in Medicare, they are spending a lot on their medications. AARP has urged lawmakers to address the issue of high drug prices.
A new study has found that more than 50% of young American children have detectable levels of lead, while about 2% had a considerably high level of lead in their blood. These findings raise public health concerns in the United States, prompting experts to take necessary precautions right away.